11 research outputs found
The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
Get PDFSince 1990, several techniques have been developed to photochemically inactivate pathogens in platelet concentrates, potentially leading to safer transfusion therapy. The three most common methods are amotosalen/UVA (INTERCEPT Blood System), riboflavin/UVA-UVB (MIRASOL PRT), and UVC (Theraflex-UV). We review the biology of pathogen inactivation methods, present their efficacy in reducing pathogens, discuss their impact on the functional aspects of treated platelets, and review clinical studies showing the clinical efficiency of the pathogen inactivation methods and their possible toxicity
Lymphome et agglutinines froides à propos d'une observation
No full textLymphome et agglutinines froides à propos d'une observatio
AcuStar HIT-IgG and heparin-induced multiple electrode aggregometry: a useful combination for rapid diagnosis of type-II HIT
No full textAcuStar HIT-IgG and heparin-induced multiple electrode aggregometry: a useful combination for rapid diagnosis of type-II HIT
No full textAcuStar HIT-IgG and heparin-induced multiple electrode aggregometry: a useful combination for rapid diagnosis of type-II HIT
No full textAcuStar HIT-IgG and heparin-induced multiple electrode aggregometry: a useful combination for rapid diagnosis of type-II HIT
No full text
